Skip Navigation LinksHome > October 2007 - Volume 7 - Issue 5 > Future directions in therapeutic interventions for conjuncti...
Current Opinion in Allergy & Clinical Immunology:
doi: 10.1097/ACI.0b013e3282ef69e3
Eye allergy

Future directions in therapeutic interventions for conjunctival inflammatory disorders

Pflugfelder, Stephen C; Stern, Michael E

Collapse Box


Purpose of review: To review recent advances in pathogenesis and treatment of conjunctival inflammatory disorders.

Recent findings: The conjunctiva becomes inflamed in a number of conditions, including allergy, atopy, dry eye, mucus membrane pemphigoid, Stevens-Johnson syndrome and surgical manipulation. Basic and clinical studies have identified a number of inflammatory mediators as potential therapeutic targets in these conditions. Additionally, new therapeutic agents and enhanced delivery systems have been evaluated.

Summary: Increased understanding of the key mediators of conjunctival inflammation coupled with improved drug delivery methods are leading to more effective therapy for conjunctival inflammatory disorders.

Copyright © 2007 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.